JOYCE ERONY
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
NARENDRA BORKAR, NARENDRA N. BORKAR, BHASKAR CHAUDHURI, JENNIFFER COLLINS, JANE ERONY, PHILIP FORTE, PHILLIP S. FORTE, JAMES GALE, JAMES D. GALE, JASON GRENFELL-GARDNER, JANE E. HAGER, MICHAEL HEMRIC, MICHAEL B. HEMRIC, JUSTINE KOSTKA, NADYA LAWRENCE, RAJIV MATHUR, CHARLES MOORE, STEVEN J. MORRIS, TERRENCE O-DONNELL
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
FOUAD AZZAM, RANDY BAN, SCOTT F. DREES, WILLIAM HARRINGTON, STEPHEN R. HAYNES, JOSEPH J. JANKOWSKI, JOSEPH JOHN JANKOWSKI, ALAN KAGANOV, MARC-ANDRE MARCOTTE, ANTHONY NATALE, CLAIBORNE R. RANKIN, CLAIBORNE READ RANKIN, JON J. SNYDER, JON JOSEPH SNYDER, ZACH STASSEN, CASEY TANSEY, MARK W. TEAGUE, DAVID VEINO, THOMAS C. WILDER
DIRECTOR
PAUL BAE, JOHN BAKEWELL, JOHN K. BAKEWELL, SHLOMO BEN-HAIM, JOSEPH CAPPER, JOSEPH H. CAPPER, HARRISS T CURRIE, HARRISS T. CURRIE, ROBERT FAULKNER, GERALD M HAINES, SHING YAN HO, JEFFREY B JUMP, SIMEON I KEDIKOGLOU, SIMOS I KEDIKOGLOU, SIMEON I. KEDIKOGLOU, M.D., GLENN MUIR, GLENN P. MUIR, SHLOMI NACHMAN, GUIDO NEELS, ANTONY W OWERS, KONSTANTIN POUKALOV, DAVID PRUTCHI, DAVID PRUTCHI, PH.D., DANIEL SCAVILLA, JASON SPEES, JAMES TOBIN, JAMES R. TOBIN, SCOTT WAY, SHING H YAN, SHING HO YAN, RUI YANG
DIRECTOR
JORDAN BAJOR, LOUIS BALDINO, ROBERT BROWN, MIKE CARUSI, DOUG FISHER, LINDA GRAIS, GREG GREIFELD, KEN HAAS, HUGO HARROD, CHANDRA LEO, CHANDRA P. LEO, JONATHAN MACQUITTY, JONATHAN MCQUITTY, DAVID NEUSTAEDTER, ROBERT O-HOLLA, ROBERT H. O-HOLLA, CHRISTOPHER OWENS, CHRISTOPHER M. OWENS, DAVID PACITTI, TOM RODGERS, ALEXANDER SCHMITZ, JEFFREY SCHWARTZ, SUSAN STIMSON, KAREN TALMADGE, DARRIN UECKER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2012-12-21
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
2010-12-21
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$5,000,001 - $25,000,000
Equity
2010-12-08
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
$1,000,001 - $5,000,000
Equity
2010-03-29

